Virtu Financial’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-12,749
| Closed | -$68K | – | 2197 |
|
2024
Q4 | $68K | Buy |
+12,749
| New | +$68K | ﹤0.01% | 1104 |
|
2023
Q2 | – | Sell |
-17,377
| Closed | -$27K | – | 2156 |
|
2023
Q1 | $27K | Buy |
+17,377
| New | +$27K | ﹤0.01% | 1191 |
|
2022
Q3 | – | Sell |
-45,455
| Closed | -$76K | – | 2331 |
|
2022
Q2 | $76K | Buy |
+45,455
| New | +$76K | 0.01% | 1005 |
|
2019
Q4 | – | Sell |
-18,155
| Closed | -$71K | – | 1935 |
|
2019
Q3 | $71K | Buy |
+18,155
| New | +$71K | 0.01% | 1141 |
|
2017
Q4 | – | Sell |
-63,189
| Closed | -$272K | – | 3118 |
|
2017
Q3 | $272K | Buy |
+63,189
| New | +$272K | 0.01% | 1488 |
|